Clinical Trials in Los Angeles

Showing 7081-7100 of 16,901 trials

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

NCT03252431

This is a randomized, multi-center, single dose, open-label and Neulasta controlled phase 3 study to evaluate the efficacy and safety of F-627 in women with Stage I - III invasive breast cancer receiving chemotherapy treatment.

Breast CancerNeutropenia

EVIVE Biotechnology393 participantsStarted Apr 2018

Los Angeles, California, United States

COMPLETEDNA< 1 mile

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

NCT02505919

A prospective multicenter randomized blinded study comparing Aquablation of the prostate with the AQUABEAM System and TURP for the treatment of Lower Urinary Tract Symptoms (LUTS). The primary endpoints for safety and effectiveness were measured at 3 and 6 months, respectively, and subjects were followed out to 5 years to collect long-term clinical data.

Benign Prostatic Hyperplasia (BPH)

PROCEPT BioRobotics184 participantsStarted Oct 2015

Birmingham, Alabama, United States • La Mesa, California, United States • Los Angeles, California, United States +14 more locations

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Find Trials by Condition in Los Angeles

Smarter Care Virginia, Examining Low-Value Care in Virginia

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Levocarnitine in Treating Fatigue in Cancer Patients

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Dissemination and Implementation of Stroke Prevention Looking at the Care Environment

Harvoni Treatment Porphyria Cutanea Tarda

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp